Join to View Full Profile
6400 Fannin StSuite 2800Houston, TX 77030
Phone+1 713-486-8000
Dr. Hsu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Texas M D Anderson Cancer CenterFellowship, Neuro-Oncology, 1999 - 2001
New York Presbyterian Hospital (Cornell Campus)Residency, Neurology, 1996 - 1999
Yale-New Haven Medical CenterInternship, Internal Medicine, 1995 - 1996
The Warren Alpert Medical School of Brown UniversityClass of 1995
Certifications & Licensure
TX State Medical License 2002 - 2026
American Board of Psychiatry and Neurology Neurology
Clinical Trials
- A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma Start of enrollment: 2011 Dec 01
- Dose-Escalation Study of TPI 287 + Avastin Followed by Randomized Study of the Same Versus Avastin for Glioblastoma Start of enrollment: 2013 Aug 01
- Safety & Efficacy Study of TPI 287 + Avastin in Adults With Glioblastoma That Progressed Following Prior Avastin Therapy Start of enrollment: 2014 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- Targeting tGLI1, a novel mediator of tumor therapeutic resistance, using Ketoconazole sensitizes glioblastoma to CDK4/6 therapy and chemoradiation.Yang Yu, Austin Arrigo, Ankush Chandra, Chuling Zhuang, Mariana K Najjar
Biorxiv. 2025-02-26 - The Use of Apparent Diffusion Coefficient Values for Differentiating Bevacizumab-Related Cytotoxicity from Tumor Recurrence and Radiation Necrosis in Glioblastoma.Kamand Khalaj, Michael A Jacobs, Jay-Jiguang Zhu, Yoshua Esquenazi, Sigmund Hsu
Cancers. 2024-07-02 - Phase 1 trial of TPI 287, a microtubule stabilizing agent, in combination with bevacizumab in adults with recurrent glioblastoma.Samuel A Goldlust, Louis B Nabors, Sigmund Hsu, Nimish Mohile, Paul J Duic
Neuro-Oncology Advances. 2024-01-18
Journal Articles
- MRI-Guided Radiotherapy for Head and Neck Cancer: Initial Clinical ExperienceM Cao, S Hsu, Y Yang, M L Steinberg, A M Chen, J Lamb, Clinical & translational oncology
Press Mentions
CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Moves Closer to IND Filing as Manufacturing of Lead Drug Candidate CommencesOctober 23rd, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
